Antineoplastic Agents, Alkylating

All categories
DBCAT000592Pharmacologic class

A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to... A DrugBank category of 41 drugs. 21 of them are approved.

Also known as
Alkylating Agents, Antineoplastic · Alkylating Antineoplastic Agents · Alkylating Antineoplastic Drugs · Alkylating Antineoplastics · Alkylating Drugs, Antineoplastic
Drugs

and 16 more with a free account

What you can answer from here — as of August 24, 2016

41DrugsEach linked to its full drug card
Sign in
29Drug targetsEvery drug–target pair in the class, with bond type
Sign in
1,930Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
16Routes of administrationHow the drugs in this class are given
Sign in
1SubcategoryNarrower classes within this one
Sign in

Which targets do Antineoplastic Agents, Alkylating share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In